Prognosis of incidental pulmonary embolism vs. symptomatic pulmonary embolism in cancer patients: a single-center retrospective cohort study in China

Table 5 Outcomes of cancer patients with IPE and SPE.

	IPE	SPE	P-value
All patients	N = 88	N = 92
Follow-up time, median, IQR, d	314.5 (141.25–620.25)	192 (54.25–544.5)	0.033^*
Bleeding events	8 (9.1)	10 (10.9)	0.691
Recurrent VTE	5 (5.7)	10 (10.9)	0.208
Underwent follow-up radiology	69 (78.4)	46 (50.0)	0.001^*
Mortality	36 (40.9)	57 (62.0)	0.005^*
Mortality in 30 days	0 (0.0)	9 (9.8)	0.003^*
Mortality in 90 days	3 (3.4)	18 (19.6)	0.001^*
Patients who underwent follow-up radiology	N = 69	N = 46
Recurrent VTE	5 (7.2)	10 (21.7)	0.024^*

Unless otherwise noted, data are presented as n (%)
IPE, incidental pulmonary embolism; SPE, symptomatic pulmonary embolism; PE, pulmonary embolism; IQR, interquartile range; VTE, venous thromboembolism; * means P < 0.05

ISSN: 1477-9560